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During infection, CD8+ T cells not only respond to
antigenic signals through their T cell receptor (TCR)
but also incorporate inflammatory signals from cyto-
kines produced in the local infected microenviron-
ment. Transient TCR-mediated stimulation will result
in programmed proliferation that continues despite
removal of the antigenic stimulus, but it remains
unclear whether brief exposure to specific cytokines
will elicit similar effects. Here, we have demonstrated
that brief stimulation of memory T cells with inter-
leukin-12 (IL-12) and interleukin-18 (IL-18) results in
tightly regulated programmed proliferation, in addi-
tion to acquisition of enhanced virus-specific cyto-
kine production and cytolytic activity. CD8+ T cells
briefly exposed to IL-12 and IL-18 in vitro showed
improved antiviral activity in vivo, as demonstrated
by increased proliferation and reduced viremia.
These results indicate that even transitory exposure
to inflammatory cytokines can provide a selective
advantage to infiltrating CD8+ T cells by triggering
a developmental program that is initiated prior to
direct contact with virus-infected cells.
INTRODUCTION
T cell exposure to inflammatory cytokines is common during viral
and microbial infections, but little is known about the short-term
or long-term consequences that this might have on pre-existing
memory T cells or their subsequent antiviral functions. Although
the majority of T cells that respond to a given infection are
antigen specific (Butz and Bevan, 1998; Miller et al., 2008; Mur-
ali-Krishna et al., 1998), heterologous infection might nonethe-
less trigger a degree of bystander activation and proliferation
of memory T cells (Ehl et al., 1997; Kim et al., 2002; Masopust
et al., 2007). This might be due to a combination of inflammatory
cytokine release (Kim et al., 2002; Tough et al., 1997), as well as
potential stimulation by cross-reactive peptide epitopes (Brehm
et al., 2002). Further studies have indicated that administration of
inflammatory agents, such as lipopolyssacharide (LPS) or poly
I:C, will also induce limited CD8+ T cell proliferation in vivo (Kim
et al., 2002; Tough et al., 1997), but it is unclear which cytokines
are induced under these conditions or how long T cells areexposed to the inflammatory microenvironment. Although it
was initially believed that continuous antigenic stimulation was
required for maintaining CD8+ T cell proliferation, several studies
have demonstrated that T cells might undergo programmed
proliferation in the absence of continued stimulation through
the TCR (Kaech and Ahmed, 2001; Masopust et al., 2004; Mer-
cado et al., 2000; van Stipdonk et al., 2003; van Stipdonk
et al., 2001; Wong and Pamer, 2001, 2004). Bearing this in
mind, a number of questions remain. For instance, can cytokines
alone trigger programmed proliferation and differentiation of
memory T cells after removal of the initial inflammatory signal?
Could nonantigenic, cytokine-induced programmed proliferation
of CD8+ T cells have a measurable impact on their antiviral
functions?
In these studies, we examined several memory T cell
characteristics, including proliferative capacity, cytokine pro-
duction, and cytolytic potential, after a brief (5 hr) exposure
to a defined inflammatory microenvironment containing cyto-
kines interleukin-12 (IL-12) and interleukin-18 (IL-18). We found
that virus-specific memory T cells did not require further anti-
genic stimulation in order to initiate programmed proliferation
in response to IL-12 and IL-18 and that during the course of pro-
grammed proliferation, these cells differentiated into strong
effector T cells with enhanced antiviral functions. Moreover, brief
exposure to IL-12 and IL-18 provided a proliferative advantage
during acute viral infection in vivo and resulted in reduced
viremia. The programmed proliferation induced by IL-12 and
IL-18 in CD8+ T cells was tightly regulated by CD4+ T cell help
in the form of local paracrine interleukin-2 (IL-2) production,
and this might be a mechanism for limiting excessive bystander
activation of T cells during heterologous infection. On the basis
of these results, we propose a model in which memory CD8+
T cells begin to proliferate and differentiate into activated
effector T cells upon encountering an inflammatory microenvi-
ronment found at the periphery of a site of infection and that
this enhances the host CD8+ T cell response by initiating a prolif-
erative program and upregulating antiviral functions (e.g.,
enhanced cytokine production and cytolytic activity) prior to
engagement with virus-infected target cells during migration
into the infectious foci.
RESULTS
ProgrammedProliferation of Virus-SpecificCD8+ TCells
after Exposure to IL-12 and IL-18
IL-12 and IL-18 are well-established activators of CD8+ T cells
(Freeman et al., 2012), and exposure to this cytokineImmunity 38, 131–139, January 24, 2013 ª2013 Elsevier Inc. 131
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Figure 1. IL-12 and IL-18 Program CD8+ T Cells to Proliferate in the Absence of Stimulation through the TCR
Spleen cells from LCMV-immune mice (>100 days postinfection) were labeled with CFSE and cultured for 5 hr with medium, plate-bound CD3 antibody, or IL-12
and IL-18 (10 ng/ml each). Cells were washed and then cultured for 3 days in (A) medium alone, (B) medium containing neutralizing IL-2 antibody (10 mg/ml), (C)
medium after depletion of CD4+ T cells, or (D) medium in which CD4+ T cells were depleted and cultures were supplemented with exogenous IL-2 (1.5 ng/ml). Dot
plots were gated on CD8+ T cells, and the associated histograms were gated on NP118-tetramer+ CD8+ T cells (thick solid line) or NP118-tetramerCD8+ T cells
(thin line, gray fill). Proliferation is indicated by the step-wise loss of CFSE label. After 3 days of in vitro culture, NP118-tetramer+ CD8+ T cell recoveries were 3.93
104 (IL-12 and IL-18), 3.2 3 104 (CD3 antibody), and 3.1 3 104 (medium) per well. Data are representative of six experiments.
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Programmed Proliferation by IL-12 and IL-18combination leads to the rapid activation of T cells specific to
lymphocytic choriomeningitis virus (LCMV) and the production
of interferon-g (IFN-g) at concentrations that are comparable to
that elicited by stimulation through the TCR (Figure S1A, avail-
able online [Beadling and Slifka, 2005; Raue´ et al., 2004]). This
phenomenon is limited to CD8+ T cells with a CD11ahi phenotype
because naive T cells with a CD11alo phenotype are unrespon-
sive to stimulation by this cytokine pair (Raue´ et al., 2004). In
addition, exposure to IL-12 and IL-18 or TCR stimulation by
plate-bound CD3 antibody for as little as 5 hr induced upregula-
tion of CD69 (Figure S1B), an early marker of T cell activation and
an inhibitor of T cell egress from sites of inflammation (Shiow
et al., 2006), as well as upregulation of CD25 (Figure S1C),
another important activation marker that also comprises
a subunit of the high-affinity IL-2 receptor. These observations132 Immunity 38, 131–139, January 24, 2013 ª2013 Elsevier Inc.indicate that both TCR stimulation and cytokine stimulation are
effective at activating CD8+ T cells, but little is known about
the downstream outcome on proliferation, cytokine production,
or cytolytic activity when measured in parallel. For these studies,
spleen cells frommice infected with LCMV were stained with the
vital dye carboxyfluorescein diacetate succinimidyl ester (CFSE),
which has been used extensively for examining the role of cell
division in the differentiation of T cells (Bird et al., 1998; Goldrath
et al., 2000; Murali-Krishna and Ahmed, 2000; Murali-Krishna
et al., 1999). After 3 days of in vitro culture, LCMV-NP118-
tetramer+ CD8+ T cells that had been precultured for 5 hr in
medium alone failed to proliferate without exposure to either
cytokines or antigenic stimulation through the TCR (Figure 1A).
As expected, 5 hr of preactivation with CD3 antibody was suffi-
cient to trigger programmed proliferation by a subset of T cells
Immunity
Programmed Proliferation by IL-12 and IL-18after removal of the TCR-mediated stimulus. Similarly, we
found that a subpopulation of LCMV-NP118-specific CD8+
T cells that had been preactivated with IL-12 and IL-18 for just
5 hr also reproducibly underwent three to four rounds of cell
division in the absence of activation through the TCR (Figure 1A
and data not shown). Residual IL-12 and IL-18 were not a factor
because >99.999% of these cytokines were removed during
the washing steps performed immediately after the initial 5 hr
stimulation period (Beadling and Slifka, 2005). To determine
the mechanisms underlying the observed programmed prolifer-
ation of T cells after either TCR-mediated or cytokine-mediated
stimulation, we cultured the preactivated T cells in medium
containing a neutralizing IL-2 antibody (10 mg/ml). Blocking IL-2
activity resulted in sharply reduced programmed proliferation
(Figure 1B). Autocrine IL-2 production by the brief stimulation
of CD8+ T cells (Feau et al., 2011; Spierings et al., 2006) was
an unlikely mechanism of action because we found that purified
CD8+ T cells (obtained by magnetic activated cell sorting
[MACS]) that were preactivated with either CD3 antibody or
IL-12 and IL-18 failed to proliferate in vitro unless the cultures
were supplemented with exogenous IL-2 (Figure S1D). To deter-
mine whether CD4+ T cells were the cellular source of IL-2, we
specifically depleted CD4+ T cells by MACS (>90% depletion;
data not shown) prior to the 3 day culture period (Figure 1C).
Removal of CD4+ T cells resulted in dramatic inhibition of CD8+
T cell proliferation induced by brief exposure to CD3 antibody
or IL-12 and IL-18, thus indicating a need for CD4+ T cell help
in this process. Culturing purified CD8+ T cells from LCMV-
immune mice with naive CD4+ T cells in a mixed splenocyte
population was insufficient to rescue cytokine-induced pro-
grammed proliferation (Figure S1E), further suggesting the
importance of local cross-talk between memory CD4+ and
CD8+ T cell populations during the early stages of an inflamma-
tory immune response. Although CD4+ T cells provide help to
CD8+ T cells (Matloubian et al., 1994; Shedlock and Shen,
2003; Sun and Bevan, 2003; von Herrath et al., 1996) by a variety
of means, including CD40-CD40L interactions (Andreasen et al.,
2000; Borrow et al., 1996; Whitmire et al., 1996) or secretion of
stimulatory cytokines such as interleukin-21 (Elsaesser et al.,
2009; Gagnon et al., 2008; Yi et al., 2009), the fact that we found
that specific depletion of IL-2 alone blocked CD8+ T cell prolifer-
ation (Figure 1B) indicates that this cytokine is necessary for
programmed proliferation to proceed. CD8+ T cells appeared
to be highly sensitive to low concentrations of IL-2 given that
only a small fraction of CD4+ T cells from LCMV-immune mice
spontaneously produced IL-2 directly ex vivo, and this was
not augmented by incubation with IL-12 and IL-18 (Figure S2A).
To determine whether IL-2 was sufficient to orchestrate
programmed proliferation, we supplemented CD4+ T cell-
depleted cultures with exogenous IL-2 (1.5 ng/ml) during the
3 day culture period (Figure 1D). Although virus-specific memory
T cells cultured in medium alone remained nonresponsive to
low-dose IL-2, programmed proliferation by CD8+ T cells stimu-
lated by either CD3 antibody or IL-12 and IL-18 was restored
(Figure 1 and Figures S1D and S1E). Together, these results indi-
cate that IL-2 is both necessary and sufficient for programmed
proliferation of CD8+ T cells in vitro after stimulation through
the TCR or after a brief encounter with inflammatory cytokines
IL-12 and IL-18.Cytokine-Induced Proliferating CD8+ T Cells
Demonstrate Enhanced Peptide-Specific Cytokine
Production
Previous studies have shown an association between prolifera-
tion and enhanced T cell effector function (Auphan-Anezin
et al., 2003; Baje´noff et al., 2002; Bird et al., 1998; Murali-Krishna
and Ahmed, 2000; Opferman et al., 1999). In the next series of
experiments, we examined the link between proliferation and
peptide-specific cytokine responses by memory T cells that
had been briefly cultured in medium (negative control) or presti-
mulated for 5 hr with CD3 antibody or the combination of IL-12
and IL-18 prior to 3 days of culture in unsupplemented medium
(Figure 2). The majority of memory T cells that were cultured in
medium alone remained CFSEhi, indicating that they had not
proliferated during the 3 day culture period. As expected, their
cytokine profile maintained a largely ‘‘memory’’ phenotype
(Belz et al., 2001; Slifka and Whitton, 2000), and 90% of the
IFN-g+ CD8+ T cells also produced tumor necrosis factor
a (TNF-a) after 6 hr of stimulation with LCMV-NP118-coated
A20 cells (Figure 2). Parallel analysis using NP118-tetramer
staining showed approximately a 1:1 ratio between NP118-
tetramer+ CD8+ T cells and IFN-g+ CD8+ T cells after peptide
stimulation, indicating that there were no overtly dysfunctional
T cells observed at 3 days after treatment with medium, CD3
antibody, or IL-12 and IL-18 (data not shown). Antiviral CD8+
T cells that had been previously stimulated with CD3 antibody
demonstrated normal or reduced TNF-a production after
peptide stimulation: 57% of undivided CFSEhi IFN-g+ CD8+
T cells coexpressed TNF-a, and 84% of T cells that had under-
gone one or more rounds of cell division (CFSElo/int) remained
capable of producing both cytokines after antigenic stimulation.
Brief pre-exposure to IL-12 and IL-18 at 3 days prior to viral
peptide stimulation did not greatly alter the proportion of CD8+
T cells that expressed these cytokines given that 87%–90% of
the IFN-g+ NP118-specific CD8+ T cells maintained an IFN-g+
TNF-a+ cytokine profile regardless of cell division.
We found that brief prior exposure to CD3-antibody stimula-
tion resulted in a modest defect in IL-2 production after subse-
quent peptide stimulation (Figure 2B). Although 25%–30% of
LCMV-specific CD8+ T cells cultured in medium alone were
capable of producing IL-2 after peptide restimulation, T cells
that had proliferated after brief TCR-mediated activation showed
a reduction in IL-2 production, and <20% of virus-specific CD8+
T cells produced this important cytokine after exposure to
cognate peptide. In contrast, antiviral CD8+ T cells that under-
went programmed proliferation after transient exposure to IL-
12 and IL-18 demonstrated a substantially enhanced capacity
for IL-2 production after peptide stimulation; approximately
40%–60% of virus-specific IFN-g+ CD8+ T cells were capable
of producing IL-2 (Figure 2B and data not shown). This indicates
that peptide-specific IL-2 production was approximately three
times higher in CD8+ T cells undergoing cytokine-mediated pro-
grammed proliferation than in CD8+ T cells undergoing TCR-
mediated programmed proliferation (p = 0.001).
Not only did brief exposure to inflammatory cytokines (IL-12
and IL-18) prior to antigenic stimulation with cognate peptide
3 days later result in a higher frequency of IFN-g+ TNF-a+ IL-2+
T cells (Figures 2A and 2B and data not shown), but these
activated T cells also produced significantly more IFN-g andImmunity 38, 131–139, January 24, 2013 ª2013 Elsevier Inc. 133
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Figure 2. Virus-Specific CD8+ T Cells Preactivated by IL-12 and IL-18 Respond Better to Subsequent Peptide Stimulation
CFSE-labeled cells from LCMV-immune mice were cultured in medium, IL-12 and IL-18, or plate-bound CD3 antibody for 5 hr, washed, and cultured in medium
alone for 3 days. Next, cells were stimulated with NP118-peptide-coated A20 cells for 6 hr, and IFN-g, TNF-a, and IL-2 production was determined by analysis of
intracellular-cytokine staining. CD8+ T cells were gated on divided (CFSElo/int) or undivided (CFSEhi) cell populations, and the numbers in the quadrants indicate
the percentage of CD8+ T cells producing (A) IFN-g and TNF-a or (B) IFN-g and IL-2. In the absence of peptide stimulation, baseline TNF-a and IL-2 responses
were% 0.5%, and IFN-g was identified in 0.03%–6% of CD8+ T cells (Figures S2B and S2C).
(C) The mean fluorescence intensity (MFI) of cytokine expression was quantitatively determined, and the amounts of cytokine production by divided
(CFSElo/int) CD8+ T cells or undivided (CFSEhi) CD8+ T cells under each condition were compared to the cytokine expression by undivided CFSEhi CD8+ T cells
previously cultured in medium alone. A single asterisk (*) indicates p < 0.02, and two asterisks (**) indicate p < 0.001. Data show the average and SD of three
experiments.
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Programmed Proliferation by IL-12 and IL-18TNF-a on a per-cell basis than did peptide-stimulated T cells
previously cultured in medium alone (Figure 2C). This indicates
that even several days after brief exposure to inflammatory cyto-
kines, virus-specific CD8+ T cells remain poised to elicit strong
antiviral cytokine responses after subsequent encounter with
virus-infected (or in this case, peptide-coated) target cells.
Brief Exposure to IL-12 and IL-18 Results in
Differentiation of Memory T Cells into Cytolytic
Effectors
Acquisition of strong cytolytic activity is a key aspect of
a successful immune response mediated by CD8+ T cells, and
brief exposure to IL-12 and IL-18 for as little as 5 hr is sufficient
to program virus-specific memory T cells to differentiate into
highly cytolytic effector T cells (Figure 3). Unlike CD8+ T cells
cultured in medium alone, prior exposure to stimulation with
either CD3 antibody or IL-12 and IL-18 resulted in substantial
upregulation of granzyme B expression by virus-specific
NP118-tetramer+ CD8+ T cells (Figure 3A). As might be ex-134 Immunity 38, 131–139, January 24, 2013 ª2013 Elsevier Inc.pected, NP118-specific CD8+ T cells that had proliferated (i.e.,
CFSElo/int) also expressed even higher amounts of granzyme B
than did T cells that had not undergone programmed prolifera-
tion. To determine whether prior stimulation history would alter
direct virus-specific cytolytic activity, we incubated MACS-
purified CD8+ T cells with peptide-coated target cells at the indi-
cated NP118-tetramer+ CD8+ T cell effector-to-target (E:T) ratios
(Figure 3B). NP118-specific CD8+ T cells that had been cultured
in medium alone showed only modest killing of peptide-coated
target cells at the highest E:T ratios (<25% specific lysis). In
contrast, memory CD8+ T cells that had been stimulated with
CD3 antibody or IL-12 and IL-18 at 3 days prior to the CTL assay
demonstrated strong and equally efficient lysis of peptide-
coated target cells. Collectively, these data show that a brief
encounter with inflammatory cytokines, such as IL-12 and
IL-18, can induce in virus-specific CD8+ T cells changes that
result in programmed proliferation of daughter cells that differen-
tiate into more effective antiviral CD8+ T cells—even days after
removal of the initial stimulus.
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Figure 3. Memory TCells Efficiently Kill Peptide-Coated Target Cells
after Brief Activation by IL-12 and IL-18
Splenocytes containing virus-specific CD8+ T cells from LCMV-immune mice
(>120 days postinfection) were cultured in medium or stimulated with either
plate-bound CD3 antibody or IL-12 and IL-18 for 5 hr. The cells were then
washed and incubated for 3 days without additional stimulation.
(A) For the assessment of granzyme B expression at 3 days after exposure to
stimulation with cytokines or CD3 antibody, T cells were segregated into
undivided (CFSEhi) and divided (CFSElo/int) groups and were stained for CD8,
NP118 tetramer, and intracellular granzyme B. NP118-tetramer CD8+ T cells
cultured in medium alone (Tet) served as a staining control. The numbers
indicate the MFI of granzyme B in virus-specific T cells grown under the
indicated conditions.
(B) At 3 days after brief stimulation with IL-12 and IL-18 or CD3 antibody, CD8+
T cells were purified by MACS and small aliquots of T cells were enumerated
by NP118-tetramer staining so that the peptide-specific effector-to-target
(E:T) ratio would be the same in each sample during the CTL assay. Solid lines
(closed symbols) indicate the percentage of lysis of targets coated with NP118
peptide, and dashed lines (open symbols) represent nonspecific lysis of
uncoated targets (A20 cells). Data show the average and SD of two experi-
ments.
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Programmed Proliferation by IL-12 and IL-18Prior Exposure to IL-12 and IL-18 Improves T-Cell-
Mediated Protection against Subsequent Viral Infection
Programmed proliferation in vitro might differ from the results
observed in vivo (Wong and Pamer, 2004). To determine whether
brief exposure to a defined combination of inflammatory cyto-
kines invokes a relevant change in T cell responses in vivo, we
cultured CFSE-labeled splenocytes containing approximately
1 3 105 LCMV-NP118-specific CD8+ T cells for 5 hr with
medium, CD3 antibody, or IL-12 and IL-18 prior to washing steps
to remove exogenous cytokines, and we then adoptively trans-
ferred them into congenic recipient mice (Figure 4). LCMV-
specific CD8+ T cells previously cultured in medium alone
showed no proliferation at 60 hr after transfer into uninfected
recipients (Figure 4A). Brief CD3-antibody stimulation triggered
robust programmed proliferation of virus-specific T cells aftertransfer into uninfected animals despite no further stimulation
through the TCR. In contrast, programmed proliferation by
IL-12 and IL-18 was aborted, and proliferation ceased after
only one round of proliferation. This suggests that inflamma-
tory-cytokine-induced programmed proliferation is tightly regu-
lated and stops very quickly after T cells exit an inflammatory
environment and are dispersed within uninfected tissues.
Exposure to stimulatory cytokines (e.g., IL-2) has been shown
to induce or enhance proliferation but might also be involved in
activation-induced cell death (AICD) (Waldmann, 2006) and
might negatively impact T cell memory (Pipkin et al., 2010). To
determine the long-term survival of LCMV-specific memory
T cells that have been briefly activated by CD3 antibody or
IL-12 and IL-18, we transferred T cells to uninfected recipient
mice and measured LCMV-specific donor CD8+ T cell numbers
at 7, 28, and 70 days posttransfer (Figure S3A). In the absence
of further antigenic or cytokine-mediated stimulation, we
observed no substantial difference between the survival rates
of CD3-antibody-stimulated or IL-12- and IL-18-stimulated
CD8+ T cells and CD8+ T cells that had been precultured in
medium alone. To further test the potential effects of inflamma-
tory cytokines on T cell memory, we repeatedly injected
LCMV-immune mice with LPS (which triggers IL-12 and IL-18
production by splenocytes in vitro [Raue´ et al., 2004]) and
observed no significant impact on NP118-specific CD8+ T cell
memory (p = 0.38, Figures S3B andS3C). This indicates that brief
exposure to inflammatory cytokines, such as IL-12 and IL-18,
induces proliferation and enhanced antiviral T cell activity
without causing overt AICD or loss of T cell memory.
To determine whether T cell responsiveness to subsequent
viral infection is altered by a recent history of antigenic or inflam-
matory exposure, we conducted parallel experiments in which
an equal number of T cells (1 3 105 NP118-specific CD8+
T cells) were transferred into congenic mice that were infected
with LCMV on the day of transfer (Figure 4A). Under these
conditions, CD8+ T cells that had been cultured in medium alone
proliferated rapidly during the first 60 hr after transfer into LCMV-
infected mice. Likewise, CD8+ T cells previously stimulated by
CD3 antibody also proliferated more in the infected microenvi-
ronment than they did after transfer into uninfected hosts.
CD8+ T cells that had been stimulated by IL-12 and IL-18 prior
to transfer demonstrated the highest amount of proliferation in
response to LCMV infection. Because high rates of proliferation
might not necessarily indicate that higher protective efficacy
is achieved, we also measured viremia after LCMV infection
(Figure 4B). After adoptive transfer and challenge with LCMV-
Armstrong, CD8+ T cells previously stimulated with CD3 anti-
body performed similarly to the unstimulated medium-only
controls, suggesting that 5 hr of prestimulation through the
TCR might be insufficient to elicit enhanced antiviral T cell func-
tion. In contrast, mice that received CD8+ T cells that had been
exposed to IL-12 and IL-18 for 5 hr prior to transfer showed
65%–85% lower virus titers than did naive mice that received
no T cells or naive mice that received CD8+ T cells previously
cultured in medium alone (p = 0.007 and p = 0.036, respectively).
This indicates that the enhanced antiviral functions, including
increased cytokine production, cytolytic activity, and prolifera-
tion, might have combined to provide a protective advantage
against viral infection in vivo.Immunity 38, 131–139, January 24, 2013 ª2013 Elsevier Inc. 135
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Specific CD8+ T Cell Proliferation and
Result in Decreased Viremia
LCMV-immune spleen cells from BALB/c Thy1.1
micewere labeledwith CFSE, stimulatedwith CD3
antibody (blue) or IL-12 and IL-18 (red) or incu-
bated inmedium (gray) for 5 hr, andwashedprior to
intravenous injection into BALB/c Thy1.2 mice.
(A) Recipient animals were uninfected (left panel)
or infected with 23 105 PFU LCMV-Armstrong on
the day of transfer (right panel). Proliferation of
donor CD8+ T cells in the spleen was measured at
60–62 hr after adoptive transfer via staining for
CFSE, CD8, Thy1.1, and NP118 tetramer. After
transfer, the number of NP118-tetramer+ CD8+
T cells recovered per spleen in LCMV-infected recipients was 2.6 3 104 (IL-12 and IL-18), 7.4 3 103 (CD3 antibody), and 7.9 3 103 (medium).
(B) Rapid acquisition of antiviral activity wasmeasured by the quantitation of infectious LCMV in the serum (i.e., viremia) in comparison with mice that received no
transferred cells. Data in (A) are representative of three to four mice per group from at least three experiments, and data in (B) show the results of five to six mice
per group in four experiments, except for the ‘‘no transfer’’ group, which is based on ten mice from two experiments.
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In this study, we identified programmed proliferation after tran-
sient exposure to inflammatory cytokines IL-12 and IL-18 as a
previously unrecognized feature of virus-specific T cell memory.
Although naive CD8+ T cells are largely refractory to stimulation
by IL-12 and IL-18, it was expected that the combination of IL-12
and IL-18 would activate virus-specific CD8+ T cells (Berg et al.,
2002; Berg et al., 2003; Kambayashi et al., 2003; Lertmemong-
kolchai et al., 2001; Raue´ et al., 2004; Tough et al., 2001).
However, only a brief encounter with these two inflammatory
cytokines was sufficient to also induce a developmental program
that resulted not only in continued proliferation but also in
enhanced antiviral functions that were maintained for several
days after removal of the initial stimulus. Programmed prolifera-
tion of CD8+ T cells appeared to be regulated by the availability of
local CD4+ T cell help, and we speculate that this might be an
important factor in reducing unrestricted systemic proliferation,
as well as potential T-cell-mediated immunopathology outside
of the focal zone of an active infection.
Signaling through either the TCR or the IL-12 and IL-18 recep-
tors results in the activation of a group of transcription factors
that partially, but not completely, overlap (Carroll et al., 2008;
Smith-Garvin et al., 2009; Verdeil et al., 2006; Watford et al.,
2004). TCR ligation and costimulation lead to phosphorylation
of p56lck (Lck), zeta-chain-associated protein kinase 70
(ZAP70), and linker for activation of T cells (LAT), ultimately
leading to the activation of a variety of transcription factors,
including nuclear factor kappa B (NF-kB), activator protein 1
(AP-1), and nuclear factor of activated T cells (NFAT). Binding
of IL-12 to its receptor primarily results in the activation of the
Janus kinase (Jak) and signal transducer and activator of tran-
scription (STAT) pathway via Jak2 and STAT4, aswell as the acti-
vation of the mitogen-activated protein kinase (MAPK) cascade,
particularly p38. The IL-18 receptor is a member of the inter-
leukin-1 and toll-like receptor family, and it signals via immune-
receptor-activated kinases (IRAKs) to activate NF-kB, AP-1,
and other transcription factors. Because of the commonalities
between TCR- and cytokine-induced transcription factors (e.g.,
NF-kB activation), stimulation of T cells with peptide or cytokines
results in some shared outcomes (e.g., IFN-g production and136 Immunity 38, 131–139, January 24, 2013 ª2013 Elsevier Inc.CD69 and CD25 upregulation), but not others. For instance,
TNF-a and IL-2 are induced by peptide stimulation, but not by
IL-12 and IL-18 stimulation (Beadling and Slifka, 2005). Differ-
ences between the precise combinations of signaling cascades
and transcription factors that are activated by innate versus anti-
genic signals are likely to contribute to the distinct cellular
outcomes observed after exposure to these different stimuli.
Several interrelated factors appear to be involved with the
regulation of cytokine-induced programmed proliferation and
differentiation. First, exposure to IL-12 and IL-18 initiates antiviral
IFN-g production by LCMV-specific CD8+ memory T cells within
just 1–2 hr and IFN-g expression peaks within 6–8 hr (Beadling
and Slifka, 2005; Raue´ et al., 2004). This is assumed to act as
an innate ‘‘sentinel response’’ to a local, yet unidentified micro-
bial infection (Kambayashi et al., 2003; Lertmemongkolchai
et al., 2001) prior to direct contact between the infiltrating
T cells and infected target cells. On the basis of prior studies
(Nguyen and Biron, 1999; Raue´ et al., 2004), it is likely that the
IL-12 and IL-18 concentrations used in this current study for acti-
vating CD8+ T cells in vitro are within the range of what might
occur in vivo during an inflammatory immune response. For
instance, injection of LPS into LCMV-infected mice causes up
to one-third of CD8+ T cells to become IFN-g+ within 4 hr after
administration (Nguyen and Biron, 1999), even though LPS
does not stimulate CD8+ T cells directly (Raue´ et al., 2004).
Instead, LPS triggers the endogenous production of IL-12 and
IL-18 (among other cytokines) that together elicit T cell activation
and IFN-g production. Indeed, exposing splenocytes from
LCMV-infected mice to LPS results in rapid IL-12 and IL-18
production, which subsequently triggers IFN-g production by
CD8+ T cells within just 6 hr of in vitro culture (Raue´ et al.,
2004). LPS does not trigger IFN-g production in purified CD8+
T cells, indicating that de novo production of inflammatory
cytokines by accessory splenic cells is required for mediating
this effect. Depletion of LPS-induced IL-12 and IL-18 by the
addition of neutralizing antibodies to these two specific cyto-
kines resulted in >90% reduction in CD8+ T cell-mediated
IFN-g production, demonstrating that these two cytokines are
responsible for the indirect LPS-induced T cell activation and
IFN-g expression by CD8+ T cells. Together with the data from
in vivo administration of LPS (Nguyen and Biron, 1999), these
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of secreting enough IL-12 and IL-18 within 4–6 hr to elicit T cell
activation and cytokine production similar to the results that
we observed by direct supplementation of media with defined
concentrations of these two cytokines.
In addition to rapidly producing IFN-g, memory CD8+ T cells
also upregulate CD69 and CD25 expression within 5 hr of
exposure to IL-12 and IL-18. Upregulation of CD69 inhibits
T cell egress from the zone of inflammation, acting as an impor-
tant mechanism for maintaining the local T cell population on
site until the inflammatory insult has abated. Upregulation of
CD25 also provides virus-specific memory T cells with the
capacity to respond to proliferative signals generated by IL-2.
Although the number of CD4+ T cells that spontaneously
produce IL-2 in vitro is low, it is possible that IL-12- and IL-
18-induced upregulation of high-affinity IL-2 receptor CD25 is
key to enhanced sensitivity to local IL-2 production and could
be an important mechanism for limiting CD8+ T cell proliferation
to sites of acute infection. Regulatory T (Treg) cells are also
believed to be major consumers of IL-2, and it is unknown
whether exposure to IL-12 and IL-18 alters their regulatory
functions or their IL-2 consumption in the context of an infected
local microenvironment. Interestingly, although IL-12 and IL-18
trigger strong IFN-g responses, this interaction does not elicit
detectable IL-2 production by CD8+ T cells (Beadling and
Slifka, 2005), and this mechanism most likely explains why
MACS-purified CD8+ T cells were unable to undergo pro-
grammed proliferation on their own. Likewise, purified CD8+
T cells stimulated with CD3 antibody also failed to undergo pro-
grammed proliferation, but this might have been due to insuffi-
cient activation. Prior studies examining naive CD8+ T cells
have shown that insufficient TCR-mediated stimulation results
in no further T cell expansion or only abortive clonal expansion
(Mercado et al., 2000; van Stipdonk et al., 2003). We antici-
pated that 5 hr of CD3-antibody stimulation would have been
sufficient for full activation of antigen-primed memory T cells,
especially given that this approach resulted in strong IFN-g
production, upregulation of CD69 and CD25, and programmed
proliferation in vitro and in vivo. However, brief stimulation with
CD3 antibody was not sufficient to improve rapid antiviral T cell
responses in vivo, and this might be due to a number of factors,
including the nature of the stimulus (e.g., plate-bound CD3
antibody) or the short duration of stimulation. Another important
question is how long cytokine-mediated enhancement of
antiviral CD8+ T cell function will persist. For example, one
would not expect permanent upregulation of CD69 and CD25
expression after brief exposure to an inflammatory microenvi-
ronment, and it is probable that as T cells revert back to a
resting memory state, their antiviral functions also revert back
to their baseline characteristics. Understanding the mecha-
nisms underlying these observations and determining how
long enhanced protective antiviral activity is maintained will
clearly require further studies.
During cytokine-induced programmed proliferation, activated
CD25+ CD8+ T cells were primed to proliferate when given the
appropriate signals, but this required costimulation in the form
of IL-2 production by local CD4+ T cells. This two-signal model
of programmed proliferation might explain why increased cyto-
lytic activity (Murali-Krishna et al., 1998) and limited bystanderproliferation of non-antigen-specific CD8+ T cells occurs during
heterologous infection (Masopust et al., 2007) or inflammation
(Kim et al., 2002; Tough et al., 1997) without resulting in overt
systemic proliferation of the greatermemory T cell compartment.
To determine the biological impact of cytokine-induced precon-
ditioning on antiviral T cell responses in vivo, we transferred
LCMV-specific CD8+ T cells to recipient mice that were infected
with LCMVon the same day andmonitored proliferation by CFSE
dilution. Cytokine-primed CD8+ T cells proliferated more rapidly
in the context of LCMV infection than did T cells previously
primed by CD3-antibody stimulation or cultured in medium
alone, and they demonstrated substantially improved reduction
in viremia within just 60 hr after infection. These results, along
with the observation of enhanced peptide-specific cytokine
production and cytolytic activity in cytokine-primed CD8+
T cells, provide the basis for our in vivo model. In this model,
memory T cells responding to a local inflammatory event
undergo different stages of activation, differentiation, and prolif-
eration as they near a site of infection. By secreting IFN-g at the
perimeter of the infection, an innate barrier to viral replication
and spread is initiated. As CD8+ and CD4+ T cells accumulate
at the edge of an infectious focus, programmed proliferation is
triggered, and this results in an increase in local T cell number
prior to entry into the site of infection and direct recognition of
infected targets. Once the T cells enter the site of infection, the
combined effects of cytokine-induced and TCR-driven activa-
tion and differentiation synergize to result in an enhanced anti-
viral immune response.
Together, the studies described here provide an example of
how CD4+ T cell help might be important for enhancing antiviral
CD8+ T cell function. They also provide further insight into the
complex interactions that might occur during homologous or
heterologous infection and how this might impact memory
CD8+ T cell activation, proliferation, and subsequent antiviral
function. Further studies will be needed for determining how
long the cytokine-induced enhanced state of antiviral activity is
retained by memory T cells after removal of the inflammatory
stimulus. It is also unknown whether this phenomenon is
common to all memory T cell populations or whether different
subpopulations (e.g., effector-memory or central-memory cells)
have different rates of responsiveness to inflammatory cytokine-
induced programming. Likewise, it is unknown whether pro-
grammed proliferation is unique to the combination of IL-12
and IL-18 or whether other cytokines or cytokine combinations
(Freeman et al., 2012) are able to elicit a similar enhancement
of antiviral T cell function.
EXPERIMENTAL PROCEDURES
Mice, LCMV Infection, and Adoptive Transfer
BALB/cByJ mice were either purchased from The Jackson Laboratory
(Bar Harbor, ME, USA) or bred at Oregon Health and Science University
(OHSU). BALB/c Thy1.1 mice were bred at OHSU. Mice were used at
6–12 weeks of age. LCMV-immune mice were infected intraperitoneally with
2 3 105 PFU LCMV-Armstrong, and T cell analysis was performed at 28–
170 days postinfection. For adoptive-transfer experiments, approximately
1 3 107 spleen cells containing 1 3 105 CFSE-labeled NP118-specific CD8+
Thy1.1+ T cells were transferred into Thy1.2+ mice, and T cell responses
and viremia (measured by LCMV plaque assay) were performed at 60–62 hr
posttransfer. All experimental procedures were approved by the OHSU
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HPLC-purified (>95% pure) LCMV NP118-126 (NP118) peptide (Alpha
Diagnostics, San Antonio, TX, USA) was used at 1 3 107 M. IL-2 (human
IL-2, Amgen Thousand Oaks, CA, USA) was used at 1.5 ng/ml, and IL-12
(R&D systems, Minneapolis, MN, USA) and IL-18 (Medical & Biological Labo-
ratories, Watertown, MA, USA) were used at 10 ng/ml. CD3ε antibody (clone
145-2C11, BD PharMingen, San Diego, CA, USA) was used for coating
24-well plates (20 mg/ml CD3ε antibody in PBS, 37C for 1–2 hr, and washed
before use). IL-2 antibody (clone JES6-1A12, R&D Systems) was used at
10 mg/ml to neutralize IL-2 in culture. H-2Ld NP118 tetramer was obtained
from the National Institutes of Health Tetramer Core Facility (Atlanta, GA,
USA). CD8a antibody (clone 5H10) and CD25 antibody (clone PC61 5.3)
were purchased from InVitrogen (Carlsbad, CA, USA). IFN-g antibody (clone
XMG1.2), IL-2 antibody (clone JES6-5H4), TNFa antibody (clone MP6-XT22),
CD69 antibody (clone H1.2F3), granzyme B antibody (clone CB11), and propi-
dium iodine were obtained from BD PharMingen. Thy1.1 antibody (clone
His51) was obtained from eBioscience (San Diego, CA, USA), and CFSE
was purchased from InVitrogen.
CFSE Proliferation and Intracellular-Cytokine Staining
Single-cell suspensions and in vitro stimulation conditions were performed
as previously described (Beadling and Slifka, 2005). CD8+ T cell isolation
and CD4+ T cell depletion were performed by MACS with the use of microbe-
ads coated with antibodies against CD8a or CD4 according to protocols
supplied by Miltenyi Biotec (Auburn, CA, USA). Post-MACS analysis indicated
>90% purity. Cells were labeled with 5 mM CFSE for in vivo experiments and
with 1 mM CFSE for in vitro experiments. CFSE-labeled T cells were cultured
inmedium alone, stimulated with IL-12 and IL-18 (both 10 ng/ml), or stimulated
in plates coated with CD3ε antibody in 6% CO2 at 37
C for 5 hr. Cells were
washed extensively and cultured in RPMI 10% fetal bovine serum (FBS)
supplemented with 50 mM 2-mercaptoethanol in 24-well plates for 3 days
(64–68 hr) for the assessment of proliferation. Antiviral-cytokine production
was measured by intracellular-cytokine staining 6 hr after the addition of
a 1:1 ratio of A20 cells (a B cell line) coated with 107 M NP118-126 peptide.
All flow cytometry data were analyzed with FlowJo software (Treestar,
Ashland, OR, USA).
Nonradioactive Flow-Cytometry-Based CTL Assay
A20 target cells were labeled with 4 mM (CFSEhi) or 1.5 mM (CFSElo) CFSE.
CFSElo cells were coated with peptide (107 M NP118). Target cells were
washed twice and resuspended in RPMI 10% FBS. CFSEhi and CFSElo A20
cells were combined 1:1 at 1 3 104 cells/ml (target cell suspension). For the
CTL assay, 100 ml target cell suspension was combined with 100 ml effector
cell (NP118-specific CD8+ T cells) suspensions at different E:T ratios in
round-bottom 96-well plates and incubated in 6% CO2 at 37
C for 5 hr. For
the assessment of CTL activity, cells were washed with PBS and stained
with 0.25% propidium iodine in PBS at 4C for 15 min. Samples were acquired
immediately on a FACSCalibur (BD, San Jose, CA, USA), and percent viability
was determined by propidium-iodine staining in comparison with positive and
negative controls.
Statistical Analysis
A two-tailed Student’s t test with unequal variance was used for evaluating
statistical significance of differences between groups. A value of p < 0.05
was considered significant.
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